# Bicara Therapeutics Inc.: Form SC 13D, filed Sep 18, 2024

- Company: [Bicara Therapeutics Inc.](/companies/bcax.md) (CIK 2023658)
- Form: SC 13D
- Filed: 2024-09-18
- Accepted by EDGAR: Sep 18, 2024, 17:10 ET
- Period: not reported
- Accession: 0001999371-24-012103
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/2023658/000199937124012103/bcax-sch13d_091624.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2023658/000199937124012103/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2023658/000199937124012103/bcax-sch13d_091624.htm

Filed Sep 18, 2024.
Source: SEC EDGAR, the filing index for accession 0001999371-24-012103. Last ingested by Listed: Nov 10, 2026, 02:09 ET. No prices; not investment advice.
